Use of psychoactive substances and alcohol during the first three waves of the COVID-19 pandemic : Croatian experience

Increased prevalence and severity of both substance and behavioral addictions are among the most harmful consequences of the COVID-19 outbreak.

To determine the sociodemographic characteristics, COVID-19-related stressors, and stress, anxiety, and depression symptoms that may predict the use and changes in the use of psychoactive substances (PS) during the first three COVID-19 waves in Croatia.

The cross-sectional online survey included 1,118 adult participants (220 men and 898 women; mean age: 35.1 [SD = 12.3] years; age range: 18-78) from general adult population. Sociodemographic data were collected, and ad-hoc developed questionnaires on COVID-19-related stressors, PS use before and during the pandemic, CAGE Alcohol Questionnaire, Impact of Event Scale, and Hospital Anxiety Depression Scale were applied.

The PS use increased in 31% of participants. The use of tobacco, caffeine, alcohol, cannabinoids, and anxiolytics showed the greatest increase in the last year (tobacco 7.1%; caffeine 5.8%; alcohol 6.4%; cannabinoids 2.5%; and anxiolytics 3.9%). Alcohol consumption during the pandemic increased in 16.8% of participants who consumed alcohol before the pandemic, with 4.5% of them reporting problematic alcohol use (PAU). The tested model demonstrated relatively good model-data fit and significantly predicted 11.8% increase in the use of PS and 9.8% of PAU.

Being married or in a relationship and severe anxiety and depression symptoms predicted increased use of PS and PAU, while higher education level and ever being diagnosed with COVID-19 predicted only increased use of PS.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:42

Enthalten in:

Journal of addictive diseases - 42(2024), 2 vom: 29. März, Seite 91-102

Sprache:

Englisch

Beteiligte Personen:

Kovačić Petrović, Zrnka [VerfasserIn]
Peraica, Tina [VerfasserIn]
Blažev, Mirta [VerfasserIn]
Tomašić, Lea [VerfasserIn]
Kozarić-Kovačić, Dragica [VerfasserIn]

Links:

Volltext

Themen:

3G6A5W338E
Anti-Anxiety Agents
Anxiety
COVID-19
Caffeine
Cannabinoids
Depression
Journal Article
PS and alcohol use
Stress

Anmerkungen:

Date Completed 27.03.2024

Date Revised 27.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/10550887.2022.2145076

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM34957717X